Neurologic and Cardiac Phenotype in Patients with Long QT Syndrome Type 1
Now enrolling patients with LQTS Type 1.
Quick Facts
About this study
LQTS1 families are invited to help researchers understand which neurodevelopmental findings are unique to CPVT and which are seen across other inherited arrhythmias. Your participation is essential to interpreting the results.
Researchers have noticed that some people with CPVT – especially those with variants in RYR2 – may also experience neurologic or neurodevelopmental challenges (like seizures, learning differences, attention challenges, or autism spectrum traits).
This study from the University of British Columbia (Principal Investigator: Dr. Shubhayan Sanatani) aims to:
❤️ Screen for neurodevelopmental disorders (NDD) in a large group of children with CPVT, and
❤️ Better understand the cardiac course of CPVT in children who may also have NDD features.
What are the basic eligibility criteria?
This study is for families who meet these basic criteria:
Age: 3–18 years
Diagnosis: Confirmed CPVT or LQTS1 (with or without an identified genetic variant), diagnosed at age ≤18 years.
Full eligibility will be confirmed by the research team.
Have a question? We can help you understand research options, requirements, and genetic testing – without expectation that you enroll in any particular study.
Current trial sites
This study is currently enrolling virtually throughout North America (the United States and Canada).
Neurologic and Cardiac Phenotype in Patients with Long QT Syndrome Type 1
After filling out the form below, you’ll have a chance to discuss this research study—and any questions you might have—directly with the staff at the SADS Foundation. Then a member of our team will connect you one-on-one with the research coordinator.
